TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Visiopharm LRI AB
Closing information (x1000 NOK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
20,125
|
23,968 | |
| Financial expenses |
0
|
1 | |
| Earnings before taxes |
866
|
2,261 | |
| EBITDA |
735
|
2,261 | |
| Total assets |
19,913
|
14,877 | |
| Current assets |
19,899
|
14,877 | |
| Current liabilities |
9,933
|
5,579 | |
| Equity capital |
9,724
|
8,854 | |
| - share capital |
98
|
96 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
48.8%
|
59.5% | |
| Turnover per employee |
6,708
|
7,989 | |
| Profit as a percentage of turnover |
4.3%
|
9.4% | |
| Return on assets (ROA) |
4.3%
|
15.2% | |
| Current ratio |
200.3%
|
266.7% | |
| Return on equity (ROE) |
8.9%
|
25.5% | |
| Change turnover |
-4,380
|
-4,089 | |
| Change turnover % |
70%
|
-18%
|
-15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.